Stockholders’ Equity (Details) - USD ($) |
1 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 01, 2021 |
Oct. 04, 2021 |
Sep. 14, 2021 |
Aug. 10, 2021 |
Jul. 14, 2021 |
Jan. 06, 2021 |
Dec. 28, 2021 |
Nov. 29, 2021 |
Sep. 17, 2021 |
Jun. 01, 2021 |
Feb. 28, 2021 |
May 31, 2020 |
Sep. 30, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 12, 2021 |
Oct. 14, 2021 |
Jul. 31, 2021 |
|
| Stockholders’ Equity (Textual) | ||||||||||||||||||
| Common stock per share (in Dollars per share) | $ 0.001 | $ 0.001 | ||||||||||||||||
| Convertible Preferred Stock Shares Issued (in Shares) | 65,953 | |||||||||||||||||
| (in Shares) | 25,062 | |||||||||||||||||
| Warrants to purchase common stock, description | On January 6, 2021, The Company issued 72,369 shares of common stock and 90,461 5-year warrants to purchase shares of common stock at $4.00 per share pursuant to the prior receipt of $275,000 in equity financing. | |||||||||||||||||
| Common shares issued (in Shares) | 157,582 | 298,883 | 11,293,030 | 9,895,600 | 16,666 | 157,582 | ||||||||||||
| Common stock placement (in Shares) | 298,883 | |||||||||||||||||
| Warrant additional | 5 years | |||||||||||||||||
| Warrant to purchase price | $ 1.79 | |||||||||||||||||
| Aggregate gross proceeds | $ 525,000 | |||||||||||||||||
| Common stock shares issued | $ 15,988 | $ 27,403 | $ 5,458 | $ 29,025 | $ 23,037 | $ 12,522 | $ 96,757 | $ 422,621 | $ 2,747,527 | |||||||||
| Accounts payable | $ 132,557 | |||||||||||||||||
| Fair value price per share (in Dollars per share) | $ 1.7 | $ 2.26 | $ 2.55 | $ 2.95 | $ 1.26 | $ 1.42 | $ 1.37 | |||||||||||
| Accounts payable | $ 27,178 | $ 61,930 | $ 13,919 | $ 85,622 | $ 29,027 | $ 17,781 | $ 600,000 | |||||||||||
| Common stock shares issued | 11,611 | |||||||||||||||||
| Accounts payable | $ 29,607 | |||||||||||||||||
| Fair value price per share (in Dollars per share) | $ 2.55 | |||||||||||||||||
| Legal settlement. | $ 25,000 | |||||||||||||||||
| shares of common stock | $ 6,579 | |||||||||||||||||
| Stockholders’ equity description | the Company received $515,000 of a committed $565,000 from the sale of units (at a price of $3.80 per unit) comprised in the aggregate of 135,527 shares of common stock and warrants to purchase 169,409 shares of common stock, at an exercise price of $4.00 per share. As of December 310, 2021, the full amount had not been received and only $415,000 worth of the shares and warrants have been issued. The remaining $125,000 is included in equity financing within current liabilities on the consolidated balance sheet. | |||||||||||||||||
| Unrecognized expense | $ 1,000,000 | 2,500,000 | ||||||||||||||||
| Vested Restricted Stock Units [Member] | ||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||
| Stock conversion, description | Between January 25, 2021 and August 13, 2021, the company issued a total of 504,965 shares of common stock to holders of fully vested restricted stock units. | |||||||||||||||||
| Maximum [Member] | ||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||
| Unrecognized expenses to be recognized, term | 1 year | |||||||||||||||||
| Common Stock [Member] | ||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||
| Common stock, shares authorized (in Shares) | 45,000,000 | |||||||||||||||||
| Common stock shares issued | $ 238 | $ 441 | ||||||||||||||||
| Series A Convertible Preferred Stock [Member] | ||||||||||||||||||
| Stockholders’ Equity (Textual) | ||||||||||||||||||
| Stock conversion, description | During February 2021, the Company issued 52,632 shares of common stock to a holder of its Series A Convertible Preferred Stock upon the conversion of 20,000 of such shares of Series A Convertible Preferred Stock. | |||||||||||||||||